Fabry (-Anderson) disease                                                                                                                                                                                                                                        digital illustration

Fabry (-Anderson) disease Save


ICD-10 code: E75.21

Disease category: E75.2: Other sphingolipidosis

Fabry (-Anderson) Disease: A Rare Genetic Disorder

Fabry (-Anderson) disease, also known as Anderson-Fabry disease or simply Fabry disease, is a rare genetic disorder that affects various organs and systems in the body. It is an inherited condition caused by mutations in the GLA gene, which leads to a deficiency of an enzyme called alpha-galactosidase A (α-Gal A).

While Fabry disease is considered rare, it can have significant impacts on individuals who are affected. It predominantly affects males, but females can also be carriers of the condition. The disease is characterized by the buildup of a fatty substance called globotriaosylceramide (Gb3) in cells throughout the body.

  1. Symptoms: Fabry disease can present with a wide range of symptoms that can vary in severity. Some common symptoms include:
    • Episodic pain in the hands and feet (acroparesthesias)
    • Skin rashes, particularly a reddish-purple rash called angiokeratoma
    • Gastrointestinal problems, such as abdominal pain, diarrhea, and nausea
    • Corneal opacities
    • Heart problems, including arrhythmias and an increased risk of heart attack

    It's important to note that symptoms can manifest differently in each individual, and some may experience more severe complications than others.

  2. Diagnosis: Fabry disease is often diagnosed through a combination of clinical evaluation, family history assessment, and genetic testing. Identifying the specific mutations in the GLA gene can confirm the diagnosis.
  3. Prevalence: Fabry disease is estimated to affect approximately 1 in 40,000 to 60,000 individuals worldwide. However, due to the wide range of symptoms and the possibility of misdiagnosis, the actual prevalence may be higher.
  4. Management and Treatment: While the focus of this article is not on treatment, it's worth mentioning that managing Fabry disease requires a multidisciplinary approach. Regular monitoring and treatment of symptoms are essential to improve the quality of life for affected individuals.

In conclusion, Fabry (-Anderson) disease is a rare genetic disorder caused by mutations in the GLA gene. It can result in various symptoms that affect multiple organs and systems of the body. Early diagnosis and proper management are crucial in providing appropriate care and support for individuals with Fabry disease.

Treatment of Fabry (-Anderson) disease :

Treatment Options for Fabry (-Anderson) Disease

Fabry (-Anderson) disease is a rare genetic disorder that affects the body's ability to break down a specific type of fat. This condition can lead to a range of symptoms, including pain, skin rashes, and organ damage. While there is no cure for Fabry disease, there are several treatment options available to manage its symptoms and imp...

To see full information about treatment please Sign up or Log in